European drugmakers say they are ‘losing ground’ to US and Chinese rivals

The letter calls on governments to treat medicines as strategic infrastructure, secure health sovereignty and act now to restore Europe’s competitiveness. The letter calls on governments to treat medicines as strategic infrastructure, secure health sovereignty and act now to restore Europe’s competitiveness. Pharmaceuticals industry European drugmakers say they are ‘losing ground’ to US and Chinese rivals Some of continent’s biggest pharma firms write to national leaders calling for action to safeguard their futures

Prefer the Guardian on Google Some of Europe’s biggest pharmaceutical companies have said the continent is “losing ground” to rivals including the US and China in developing new drugs and attracting investment.

The chairs of nine companies, including Britain’s AstraZeneca , GSK and Denmark’s Novo Nordisk, wrote to Andy Burnham and the national leaders of other European countries on Tuesday to call for action to “safeguard our companies’ future”.